Cite

    Tsutomu Nagai et al.. “Identification of factors associated with the efficacy of atomoxetine in adult attention‐deficit/hyperactivity disorder.” Neuropsychopharmacology reports, vol. 42, no. 3, 2022, pp. 249–255. http://access.bl.uk/ark:/81055/vdc_100167556856.0x00000b